Frits van Rhee, M.D., Ph.D., MRCP, FRCPath


Frits van Rhee, MD, PhD, is a Professor of Medicine and Director of Developmental and Translational Medicine at the UAMS Myeloma Center. He earned his medical degree from Erasmus University, Rotterdam, Netherlands and his PhD at the Imperial College of Science, Medicine and Technology, University of London. Dr. van Rhee trained in Internal Medicine and Hematology in the UK, and in Bone Marrow Transplantation at John Radcliffe University Hospital in Oxford and the Royal Postgraduate Medical School in London. He holds the Charles and Clydene Scharlau Chair for Hematological Malignancies.

Dr. van Rhee is a renowned myeloma physician who treats and follows more than 800 patients with multiple myeloma, MGUS, and smoldering myeloma, as well as other hematologic malignancies. He is a leading innovator in immunotherapy research and clinical applications, especially for patients with high-risk disease. Dr. van Rhee has been the principal investigator of NIH grants studying Natural Killer cell activity via cellular and vaccine-based approaches in myeloma.

Dr. van Rhee is also an international expert on Castleman Disease, with one of the largest populations of Castleman Disease patients in the world, and POEMS Syndrome.

Dr. van Rhee is a member of the International Society for Cellular Therapy, the International Society for Experimental Hematology, the European Group for Bone and Marrow Transplantation, the Royal college of Physicians (UK), the Royal College of Pathologists (UK), and the American Society of Hematology. He has UK board certification in Internal Medicine and Hematology.


Professional Certifications and Education

American Board of Internal Medicine, 1989
MRCPath Hematology, 1996
Fellowship: Hematology, University Hospital in Nottingham and John Radcliffe University Hospital in Oxford
Residency: Internal Medicine, United Kingdom
University: M.D. DEGREE: Rotterdam, Netherlands, 1985
University: Ph.D. DEGREE: University of London
Fellowship: Hammersmith Hospital and Royal Postgraduate Medical School, London


  • Multiple Myeloma
  • Castleman’s Disease
  • Myeloma & Transplantation
  • MGUS
  • Smoldering Myeloma
  • Waldenstrom Macroglobulinemia
  • Amyloidosis
  • POEMS syndrome

Conditions/Diseases Treated

UAMS doctors treat a broad range of conditions some of which may not be listed below.

  • Multiple Myeloma
  • Bone Marrow Transplantation
  • Castleman’s Disease
  • Lymphoma
  • MGUS
  • Smoldering Myeloma
  • MDS
  • Amyloidosis
  • POEMS Syndrome

Languages Spoken

English, Dutch
Additional Links

Patient Story – Frequent Flier

Successful Treatment of UAMS Patient for Extremely Rare Condition —video

Hospital Affiliations

  • University of Arkansas for Medical Sciences

Institute Affiliations

  • Myeloma Center for Research and Therapy

Academic Appointment

  • Professor of Medicine